Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endologix Inc (NASDAQ:ELGX)

6.89
Delayed Data
As of Feb 09
 +0.23 / +3.45%
Today’s Change
6.51
Today|||52-Week Range
18.07
-30.40%
Year-to-Date
No recent news for Endologix Inc.

Today’s Trading

Previous close6.66
Today’s open6.60
Day’s range6.51 - 6.92
Volume5,390,282
Average volume (3 months)1,136,526
Market cap$451.5M
Dividend yield--
Data as of 3:59pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)-92.31%
Earnings growth (this year)-60.53%
Earnings growth (next 5 years)+95.60%
Revenue growth (last year)+11.59%
P/E ratioNM
Price/Sales6.76
Price/Book3.60

Competitors

 Today’s
change
Today’s
% change
XENTIntersect ENT Inc+0.66+3.99%
INOInovio Pharmaceutica...-0.16-2.67%
KTWOK2M Group Holdings I...-0.18-1.48%
LDRHLDR Holding Corp-0.78-4.44%
Data as of 3:59pm ET, 02/09/2016

Financials

Next reporting dateFebruary 22, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$147.6M
Annual profit (last year)-$32.4M
Net profit margin-21.97%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
John D. McDermott
President
Robert D. Mitchell
Corporate headquarters
Irvine, California

Forecasts

Partner Offers